RESEARCH-USE BIOSIMILAR ANTIBODY

Otlertuzumab

Antibody fragment · IgG1

CD37IgG1RUO

Otlertuzumab (TRU-016) is a humanized anti-CD37 monoclonal antibody that can be used for cancer research.

TARGETCD37
YAntibody fragment
CATALOGSC-BS-299
CATALOG NUMBERSC-BS-299
MOLECULAR WEIGHTApprox. 104.8093 kDa
PRODUCT FORMATAntibody fragment

A research-use configuration for comparative antibody studies

Otlertuzumab (TRU-016) is a humanized anti-CD37 monoclonal antibody that can be used for cancer research.

Otlertuzumab is a recombinant research-use antibody directed against CD37.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte